A detailed history of Brewin Dolphin Wealth Management LTD transactions in Magenta Therapeutics, Inc. stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 1,300 shares of MGTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,300
Previous 1,300 -0.0%
Holding current value
$0
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$4.43 - $8.33 $5,759 - $10,829
1,300 New
1,300 $6,000
Q1 2021

Nov 09, 2023

BUY
$7.66 - $13.38 $5,745 - $10,035
750 Added 136.36%
1,300 $15.4 Million
Q2 2020

Nov 09, 2023

SELL
$6.18 - $10.76 $4,635 - $8,070
-750 Reduced 57.69%
550 $4.13 Million
Q3 2019

Nov 09, 2023

SELL
$9.63 - $14.0 $7,222 - $10,500
-750 Reduced 57.69%
550 $5.64 Million

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.